Vical

About:

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

Website: http://www.vical.com/

Twitter/X: VicalInc

Top Investors: Sequoia Capital, Sutter Hill Ventures, Venrock, Morgenthaler Ventures, Hilman Ventures

Description:

Vical's core technology grew out of a chance discovery and provided the cornerstones for two new biopharmaceutical industry sectors: DNA vaccines and non-viral gene therapy. Vical's management systematically leveraged that technology into a broad portfolio of independent and partnered product development programs. The first products for animal health are on the market. The first human products are approaching.